#245: The European Clinical Trials Environment Under the Accelerating Clinical Trials (ACT EU) Initiative: Two Years On
Tuesday, June 18, 2024 1:15 PM to 2:15 PM · 1 hr. (US/Pacific)
Room 5AB
02: ClinTrials -ClinOps09: Regulatory
Information
Accelerating Clinical Trials in the EU (ACT EU) and the successful launch of the clinical trial regulation have modernized the clinical trial environment. This session is focused on how Europe is embracing the change and will also present other international initiatives offering opportunities for collaboration.
CE
ACPECMERN
Session Level
Intermediate
Featured Topics
Regulator PerspectivesEthics
Speakers
Ana Zanoletty Perez
Head of Clinical Trials Transformation WorkstreamEuropean Medicines AgencyST
Shari Targum
Acting Director, Office of Clinical Policy, Office of the CommissionerFDA
Marion Laumonier
Technical Officer, Regulatory Convergence and NetworksWorld Health Organization (WHO)
Deborah Collyar
PresidentPatient Advocates In Research (PAIR)KB
Kevin Bugin
Head of Global Regulatory Policy and IntelligenceAmgen
Sara Calvert
Director of ProjectsClinical Trials Transformation Initiative (CTTI)